Susquehanna International Group, LLP Landos Biopharma, Inc. Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$0.26 - $0.55 $1,582 - $3,348	-6,088 Reduced 28.9%	14,976 $4,000
Q4 2022 Feb 14, 2023	BUY	$0.22 - $0.51 $4,634 - $10,742	21,064 New	21,064 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.6 - $1.5 $7,517 - $18,793	12,529 New	12,529 $9,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.